Axial Spondyloarthritis
Red Flags — serious mimics of inflammatory back pain
| Red flag | Why dangerous | Action |
|---|---|---|
| Acute anterior uveitis with sudden unilateral eye pain, photophobia, blurred vision, and red eye | Acute anterior uveitis can cause permanent visual loss if not treated within 24–48 hours with topical corticosteroids and mydriatics. This is not a same-week ophthalmology referral — it is a same-day emergency. The GP must recognise uveitis and refer urgently, not manage as conjunctivitis. | Urgent ophthalmology same day — not GP management |
| Progressive back pain + weight loss + age >50 or cancer history | Malignant spinal cord compression from metastatic disease mimics IBP — particularly myeloma (which occurs in younger adults) and lymphoma. Night pain + progressive course + systemic features = malignancy until proven otherwise. Do not attribute to axSpA without cancer exclusion. | Urgent whole-spine MRI + ESR/CRP/FBC/plasma electrophoresis |
| Fever + localised spine tenderness + raised inflammatory markers + IVDU or recent immunosuppression | Vertebral osteomyelitis / discitis / epidural abscess. These may present with back pain indistinguishable from IBP clinically. Blood cultures + MRI spine with gadolinium + urgent surgical/ID input. Mismanagement with NSAIDs alone can allow untreated infection to progress to epidural abscess with irreversible neurological deficit. | Emergency MRI + blood cultures + IV antibiotics |
| New neurological signs in established axSpA — bilateral leg weakness, bladder symptoms | Cauda equina syndrome from a large central disc herniation can occur in patients with pre-existing axSpA. More importantly, atlantoaxial subluxation (C1/C2 instability) occurs in advanced AS from ligamentous laxity — can cause myelopathy or sudden death with neck trauma. Any new neurological symptoms in a patient with axSpA must be investigated urgently. | Urgent MRI (whole spine including cervical) + rheumatology/neurosurgery |
| Fracture in axSpA — after even minor trauma, sudden severe pain | The ankylosed ("bamboo") spine in advanced AS is paradoxically at very high fracture risk — it behaves like a long bone and fractures transversely with relatively minor trauma. Fractures in this context are highly unstable and associated with severe neurological injury. Fracture of an ankylosed spine = emergency — do not move patient unnecessarily; C-collar if cervical; immediate imaging. | Emergency CT/MRI spine + spinal surgery |
Safeguarding Considerations
💊 Long-term NSAID Prescribing
- Continuous NSAID use (standard for axSpA management) carries significant GI, cardiovascular, and renal risks — mandatory GI protection (PPI) and annual BP/eGFR monitoring
- NSAIDs must be stopped in pregnancy — discuss this explicitly with women of childbearing age at every prescription review
- NSAIDs interact with antihypertensives (reduced BP control), anticoagulants (bleeding risk), and SSRIs (GI bleeding risk)
🧬 Biologic Safety — Anti-TNF Monitoring
- Anti-TNF biologics (adalimumab, etanercept, certolizumab) carry risk of serious infection, reactivation of latent TB, and demyelination — TB screen (IGRA/Mantoux) mandatory before initiation
- Patients on anti-TNF agents should not receive live vaccines — check vaccination status before starting biologics; offer influenza and pneumococcal vaccines before initiation
- Anti-TNF-associated lymphoma risk: inform patients and document in notes
🤰 Reproductive Health
- AxSpA predominantly affects women and men in their reproductive years. Family planning must be discussed at every consultation with women of childbearing age
- NSAIDs: avoid in first trimester (teratogenicity risk) and absolutely contraindicated in third trimester (premature closure of ductus arteriosus)
- Certolizumab pegol: the preferred anti-TNF in pregnancy as it does not cross the placenta (no Fc region). All other anti-TNFs: specialist guidance required during pregnancy and breastfeeding
🚗 Driving and Neck Safety
- Severe cervical ankylosis in advanced AS severely limits rotation — significantly impairs driving safety. Ophthalmology driving assessment if cervical involvement. DVLA notification if significant restriction
- Cervical spine instability (atlantoaxial subluxation): patients must be warned about high-velocity trauma risk (car accidents, contact sports, manipulation by non-specialists)
- Advise patients with cervical AS against chiropractic cervical manipulation — risk of catastrophic neurological injury
⏳ Diagnostic Delay and Iatrogenic Harm
The 8.5-year average diagnostic delay in axSpA is not a neutral period — it is a period of progressive unrecognised inflammation, potential irreversible radiographic damage, inadequate pain management, loss of productivity, and compounding self-doubt. Patients who have been dismissed or given incorrect management for years carry significant psychological burden alongside their physical symptoms.
"I want to acknowledge something: based on what you're describing, I think this is an inflammatory condition of the spine that responds to specific treatments — and I'm concerned that the management you've received until now hasn't been targeted for this. I'm going to refer you to a rheumatologist who specialises in this."💼 Occupational Impact and Career Concern
AxSpA predominantly affects people in their 20s and 30s — at the start of their careers. Physiotherapy, nursing, teaching, construction — physically demanding occupations are at highest risk of functional limitation. The fear of progressive disability that prevents career continuation is often the dominant motivating concern for seeking diagnosis.
"Your job as a physiotherapy assistant is physically demanding, and I understand why this is about more than just pain — it's about being able to work long-term. The good news is that with the right treatment, the majority of people with inflammatory back pain continue to work and stay active."🔴 Uveitis — the Missed Connection
Recurrent uveitis managed in isolation — by optometrists or A&E — without connecting to the back pain is one of the most common patterns of delayed diagnosis. Priya's two previous episodes of "iritis" are the strongest diagnostic signal in this consultation, and their connection to the back pain is the key diagnostic act. "Your eye problems and your back pain are almost certainly the same condition" is a paradigm-shifting statement for most patients.
"I want to ask about your eye problems — the iritis. I believe those episodes and your back pain are connected. They're both caused by the same underlying inflammation, and they will both respond to the same treatment. This is something I should have been asked about earlier."😔 Depression, Fatigue, and Fibromyalgia Overlap
Chronic pain from undiagnosed axSpA causes depression and fatigue — both directly from the disease (inflammatory cytokines directly affect mood) and indirectly from years of inadequate management and self-doubt. Central sensitisation and fibromyalgia frequently co-occur with axSpA and may reduce the response to anti-TNF therapy if not addressed simultaneously. PHQ-9 at diagnosis and every review.
"How has your mood been through all of this? Two years of unexplained pain that isn't responding to what you've been given is genuinely exhausting and demoralising. I want to make sure we're looking after that as part of the overall plan."🤰 Reproductive Planning
AxSpA is diagnosed most commonly in women and men aged 20–35 — precisely the period of reproductive planning. NSAIDs must be stopped before conception and during pregnancy. Biologic choice is affected by pregnancy. This conversation must happen proactively, not reactively (not after the patient discovers they are pregnant while on NSAIDs).
"Before I talk about the medication: are you planning a pregnancy in the near future? The reason I ask is that some of the most effective medications for this condition need to be adjusted during pregnancy, and I want to plan ahead with you rather than having to change your treatment unexpectedly."🏋️ Exercise, Swimming, and the SpA Mindset
In contrast to most musculoskeletal conditions, patients with axSpA should be strongly encouraged to exercise — and specifically to understand that exercise is a treatment, not a risk. Swimming, cycling, yoga, Pilates, and NASS-approved exercise programmes are specifically beneficial. The sedentary response to pain that is often advised for mechanical conditions is actively harmful in axSpA.
"Here is the most important lifestyle message for your condition: exercise is your best treatment. Swimming, cycling, yoga — these are not just good for general health, they are specifically anti-inflammatory for your spine. The NASS website has tailored programmes designed for people with exactly your condition."- Treating again as mechanical back pain without screening IBP criteria
- Not asking about uveitis, psoriasis, and IBD — the extra-articular features that confirm SpA
- Not making the connection between uveitis and back pain explicitly
- Ordering plain X-ray as first-line imaging — MRI SIJ is the NICE NG65-recommended investigation
- Not referring to rheumatology when ≥4/5 IBP criteria are met
Same-Day Action
Do not manage in primary care alone- Acute anterior uveitis (iritis)Unilateral painful red eye + photophobia + blurred vision — same-day ophthalmology; topical corticosteroids + mydriatics within 24h prevents permanent damage; do NOT manage as conjunctivitis
- Fracture in ankylosed spine after traumaEmergency CT/MRI spine + spinal surgery; ankylosed spine fractures are highly unstable; immobilise before imaging
- New neurological deficit in known axSpAAtlantoaxial subluxation causing myelopathy; or CES from acute disc herniation; emergency MRI + neurosurgery
- Fever + severe back pain + raised CRPDiscitis / epidural abscess — emergency MRI + blood cultures + IV antibiotics; ID/spinal surgery same day
2–4 Weeks
Rheumatology + imaging- Suspected axSpA with ≥4/5 IBP criteria — first diagnosisNICE NG65: refer to rheumatology; arrange MRI SIJ before or concurrent with referral; start NSAID trial immediately
- Disease activity breakthrough on current therapyBASDAI ≥4 despite optimised treatment — rheumatology urgent review for biologic eligibility assessment
- Recurrent or severe uveitis — subacuteOphthalmology review within 1 week; review AS/SpA disease activity with rheumatology; consider biologic optimisation
GP + Rheumatology Follow-Up
Ongoing shared care- Established axSpA, well-controlled on NSAIDsAnnual shared care review: BASDAI, BASFI, ESR/CRP, BP/lipids (CVD risk), DEXA, ophthalmology review, NSAID safety bloods
- Monitoring patients on anti-TNF biologicsRheumatology-led biologic monitoring with GP shared care for cardiovascular risk, infection screening, and vaccination
- Physiotherapy referral (SpA-specific)Hydrotherapy, spinal mobility, chest expansion — NASS-referred exercise programmes; ongoing throughout disease course
- Not flagging uveitis as same-day emergency if currently active
- Sending routine back pain referral instead of rheumatology referral per NICE NG65
- Ordering plain X-ray instead of MRI SIJ for new suspected axSpA
- Dismissing axSpA diagnosis because examination is normal (common in early disease)
- Not checking chest expansion — missing a specific axSpA finding
- Not checking enthesitis sites — missing a SpA-specific finding
- Ordering plain X-ray instead of MRI SIJ — missing early sacroiliitis
- Dismissing axSpA because MRI is normal — early disease can have normal imaging
- Not completing BASDAI before referral — misses the disease activity documentation for biologic eligibility
"Your back pain is not caused by a 'slipped disc' or by the way you hold yourself or your posture — it's caused by inflammation in the joints at the base of your spine, called the sacroiliac joints. Think of these joints as the anchors connecting your spine to your pelvis. In this condition, the immune system mistakenly attacks those joints — causing inflammation, stiffness, and pain that is classically worse after rest and better with movement. Over time, if the inflammation is not treated, those joints can gradually fuse together — which is where the old name 'ankylosing spondylitis' (ankylosing means fusing) comes from. The good news is that we have very effective treatments that control the inflammation and can prevent this progression in most people. The condition responds well to anti-inflammatory tablets, specific physiotherapy, and — if needed — to biologic injections that target the inflammation directly."
Degenerative/Mechanical Back Pain
Age typically >40 at onset; worsens with activity; improves with rest; no nocturnal waking; ESR/CRP normal; MRI shows degeneration not active inflammation. The most common misdiagnosis for axSpA.
Reactive Arthritis (Reiter's)
Triggered by GI or GU infection. Asymmetric peripheral oligoarthritis + IBP + conjunctivitis/uveitis + urethritis. HLA-B27 positive in 75%. Usually self-limiting but can cause persistent IBP.
Diffuse Idiopathic Skeletal Hyperostosis (DISH)
Older males; flowing calcification of anterior longitudinal ligament; normal SIJ on MRI; HLA-B27 negative; no inflammatory markers. Mimics late AS on plain X-ray. Rheumatology distinction.
Vertebral Osteomyelitis / Discitis
Fever + raised CRP + back pain + IVDU or immunosuppression. Emergency MRI + blood cultures. Can mimic IBP clinically. Anti-TNF initiation in unrecognised spinal infection is dangerous.
Malignancy (Myeloma, Lymphoma, Metastases)
Night pain + weight loss + age >50 or cancer history. Normal X-ray doesn't exclude — MRI mandatory. Plasma electrophoresis for myeloma. ESR often dramatically elevated.
- Saying "I can't diagnose this — only the rheumatologist can" without acknowledging the clinical probability
- Not connecting uveitis to the back pain in the diagnosis explanation
- Not acknowledging the diagnostic delay — misses a therapeutic validation opportunity
- Not referring to rheumatology — this is a NICE NG65 mandatory referral when criteria are met
- Referring without starting NSAID therapy — delays disease management during waiting time
- Not connecting uveitis to the SpA referral — ophthalmology and rheumatology involvement may both be needed
Validate — name the diagnostic journey
Priya has attended multiple appointments and been dismissed. Before discussing any treatment, the GP must acknowledge the delay. This is both ethically correct and therapeutically necessary — without acknowledgement, the management plan sits on a foundation of unresolved distrust.
"I want to start by saying: I think there has been a delay in identifying what is actually causing your back pain. What you've been experiencing — the morning stiffness, the night waking, the episodes of iritis — these are characteristic of a specific inflammatory condition, and I want to make sure we now address it properly."Explain — the diagnosis in plain terms
The immune system is attacking the sacroiliac joints. This is not posture. This is not weakness. This responds to specific treatments. Most people with this condition maintain an active life and career with the right management. The bamboo spine image is the untreated extreme — not the expected outcome with modern therapy.
"Axial spondyloarthritis is a condition where your immune system attacks the sacroiliac joints — the anchors between your spine and pelvis. Think of it as internal joint inflammation, not a structural problem. Anti-inflammatory medication, the right physiotherapy programme, and — if needed — a biologic injection can control it very effectively in most people."Negotiate — concrete actions today
Today: NSAID upgraded to naproxen 500mg BD continuously (not PRN); MRI SIJ and HLA-B27 blood test arranged; NICE NG65 rheumatology referral sent; NASS website signposted; follow-up in 4 weeks to review NSAID response before rheumatology appointment.
"Today I'm going to upgrade your anti-inflammatory prescription, arrange the MRI and blood tests the rheumatologist will need, and send the referral. While you're waiting for the specialist appointment — which I'll make urgent — you will already be on the right medication and I'll see you again in 4 weeks to see how it's helping."Warm water reduces joint stiffness (thermotherapy) while buoyancy allows full spinal range of motion without axial loading. Hydrostatic pressure reduces joint oedema. Backstroke specifically mobilises the thoracic and lumbar spine in extension — counteracting the flexion tendency of progressive AS.
NASS hydrotherapy referral or self-referral to leisure centre aquatic fitness programme. Avoid breaststroke in severe hip involvement. Warm pool preferred (33–35°C). Morning sessions most effective (counteracts morning stiffness).
NASS (National Axial Spondyloarthritis Society) provides disease-specific group exercise programmes developed by specialist physiotherapists. Evidence shows supervised SpA exercise is significantly superior to generic back physiotherapy. Components: spinal extension exercises (counteracting fusion tendency), chest expansion, deep breathing, posture correction.
NASS website (nass.co.uk) — groups across the UK. NHS physiotherapy referral specifying "axial SpA programme." Self-referral to NASS groups free of charge. Home exercise programme (NASS booklet "AS Exercises") daily. Yoga and Pilates adapted to spinal extension have supportive evidence.
Cycling provides cardiovascular conditioning without high spinal axial loading. The sitting-forward posture on a bike promotes thoracic extension relative to standing and maintains hip mobility. Stationary bike particularly useful during flares when outdoor exercise is limited.
Ergonomic handlebars (slightly raised) reduce cervical strain. Mountain biking cautioned in cervical involvement (fall risk). Stationary bike preferred in active flare. CVD risk monitoring — cycling doubles as cardiovascular protection in this high-CVD-risk population.
Costovertebral joint involvement progressively restricts chest expansion in AS. Daily breathing exercises maintain intercostal mobility and prevent the restrictive lung pattern seen in advanced disease. Deep breathing also mobilises the thoracic spine in extension — counteracting the kyphotic tendency.
Deep breathing: maximum inspiration sustained 5 seconds × 10, twice daily. Arm raises with inspiration (rib cage expansion). NASS breathing exercise programme included in home booklet. Measure chest expansion at each rheumatology review (normal >5cm; <2.5cm = significant restriction).
Smoking is an independent risk factor for radiographic progression in axSpA (accelerated syndesmophyte formation), reduced biologic treatment response, amplified CVD risk (already elevated in axSpA), and reduced bone density (already at risk from chronic inflammation). The cumulative harm of smoking in axSpA is substantial — more than in the general population.
SMSC (Smoking Cessation Service) referral at every consultation. NRT; varenicline (most effective); e-cigarettes as harm reduction. Document smoking status in every entry. Inform patient that smoking reduces anti-TNF response — this is a motivating factor specific to axSpA.
AxSpA carries a CVD risk comparable to rheumatoid arthritis — 50–60% elevated relative risk from chronic systemic inflammation driving premature atherosclerosis. Traditional Framingham calculation underestimates risk in inflammatory arthritis — apply a ×1.5 multiplier (as per NICE RA guidance, applicable to inflammatory arthritis broadly).
Annual: BP, fasting lipids, HbA1c, BMI. Framingham ×1.5 → statin threshold is lower in axSpA. Smoking cessation particularly important. Regular aerobic exercise (already recommended) has protective CVD effect. Document CVD risk score in notes annually.
Naproxen 500–1000mg/day or Diclofenac 75–150mg/day (continuous, not PRN)
- Continuous use preferred over PRN — evidence suggests continuous NSAID use slows radiographic progression in axSpA
- Dramatic NSAID response (within 24–48h) supports diagnosis of axSpA (quasi-diagnostic)
- Add PPI (lansoprazole 15–30mg OD) — mandatory with continuous NSAID in axSpA due to prolonged course
- Etoricoxib (COX-2 selective) as an alternative: equivalent efficacy, lower GI risk but higher CVD risk — use only if NSAID intolerance rather than elevated CVD risk
Sulfasalazine 2–3g/day (enteric-coated) — for PERIPHERAL joint involvement only
- NICE NG65: sulfasalazine is appropriate for peripheral arthritis in SpA — but has NO efficacy for axial (spinal/sacroiliac) disease
- Used in the waiting period before biologic initiation when peripheral joints are active
- Monitor: FBC, LFTs, eGFR at 4–6 weeks, then 3 monthly — sulphonamide component causes cytopaenias
- Safe in pregnancy (with folic acid supplementation); used in IBD-associated axSpA for bowel benefit
Anti-TNF (adalimumab/certolizumab/etanercept) or Anti-IL17 (secukinumab)
- NICE TA383/TA383B: anti-TNF therapy for active axSpA when BASDAI ≥4 despite two NSAID failures
- Anti-TNF choice: adalimumab (fortnightly SC) / certolizumab pegol (preferred in pregnancy) / etanercept (weekly SC; NOT effective in IBD) / infliximab (IV infusion, IBD-associated axSpA)
- Anti-IL17: secukinumab (monthly SC after loading) — preferred for psoriatic axSpA; anti-TNF failure; enthesitis-predominant disease
- Pre-biologic: TB screen (IGRA), FBC, LFTs, hepatitis B and C serology, vaccination review
- Certolizumab pegol: no Fc region, minimal placental transfer — preferred anti-TNF in pregnancy. Can be continued throughout all trimesters.
- Adalimumab/infliximab: IgG1 antibodies — cross placenta in 2nd and 3rd trimesters; stop at ≥20 weeks in most guidelines unless benefit outweighs risk (discuss with rheumatology)
- Etanercept: may be continued to ≥34 weeks — some placental transfer but considered lower risk than adalimumab/infliximab
- NSAIDs: avoid in first trimester (teratogenicity), absolutely stop in third trimester (premature ductus closure). May use in second trimester only if benefit clearly outweighs risk.
- Some patients on biologics have residual pain not explained by active inflammation — central sensitisation, fibromyalgia overlap, or structural damage
- Duloxetine 30→60mg OD: addresses central sensitisation component; evidence in RA and inflammatory arthritis for residual pain
- Paracetamol 1g QDS: safe to continue alongside NSAIDs and biologics for breakthrough pain
- Opioids: very limited role in axSpA — risk of dependence; not disease-modifying; can worsen the sedentary behaviour that accelerates progression
- Oral steroids: not standard in axSpA for axial disease; short courses for peripheral flares or bridging
Select patient characteristics — see drug cards and prescribing guide above
"Take this every day — not just when the pain is severe. In your condition, the anti-inflammatory effect builds up with regular use and actually reduces the underlying damage over time. Always take it with food. I'm also prescribing a stomach-protecting tablet to take alongside it."
Continuous NSAID use in axSpA may reduce radiographic progression — this is different from all other back pain where the shortest necessary duration is advised. Document the NSAID name, dose (therapeutic: naproxen ≥500mg/day), duration, and response precisely — this is required for NICE biologic funding eligibility.
"This tablet helps the joint swelling in your knees and ankles, but I want to be clear — it does not help the back stiffness directly. For the back, the ibuprofen and eventually the specialist's medication are what will work. Take this one with your largest meal, start at one tablet and build up slowly over 4 weeks."
Key SCA teaching point: sulfasalazine is NOT effective for axial spondyloarthritis. It is only appropriate for peripheral joint manifestations. Using it as the sole treatment for axial disease (instead of NSAID and biologic pathway) is a significant clinical error that would cost Tasks domain marks.
"This injection — which you'll give yourself at home — works by specifically targeting the inflammatory chemical called TNF that is driving your joint disease. Most people feel significantly better within 6–12 weeks. The most important safety message: if you develop a fever, persistent cough, or feel unwell in a way that doesn't settle in 48 hours, contact us immediately — infections need prompt treatment while on this medication."
Anti-TNF biologic eligibility: BASDAI ≥4 + two NSAID failures documented. Etanercept: NOT effective for IBD or uveitis — this is a critical prescribing distinction. Certolizumab: preferred in pregnancy (no Fc region = no placental transfer). TB screen (IGRA) is mandatory before any biologic — failure to screen is a patient safety issue.
"This injection works on a different part of the immune pathway from the TNF injection. It's particularly effective when psoriasis is also involved — treating both conditions at once. The most common side effect is oral or vaginal thrush, which is easily treated with antifungal medication. Please let us know if you develop any tummy symptoms or diarrhoea — this medication can occasionally affect the bowel in a small number of people."
Critical distinction: secukinumab (anti-IL17) WORSENS IBD — absolutely avoid in IBD-associated axSpA. Anti-TNF (adalimumab/infliximab) preferred in IBD + axSpA. Secukinumab is preferred for psoriatic axSpA. This anti-TNF vs anti-IL17 distinction based on extra-articular features (IBD vs psoriasis) is a high-yield SCA pharmacology question.
"This particular anti-TNF injection is special because it's been designed so that it does not cross the placenta — which means it is the safest biologic to use when you're pregnant or planning to become pregnant. Your rheumatologist has chosen this specifically for you, knowing that you're thinking about starting a family. You won't need to stop it during pregnancy."
Certolizumab pegol is the preferred anti-TNF for women planning pregnancy — the only anti-TNF with no significant placental transfer (absence of Fc region). Neonates born to mothers on certolizumab can receive all routine vaccinations immediately (no delayed vaccination needed). Other anti-TNFs cross the placenta in 2nd/3rd trimesters and require delayed live vaccination of the neonate.
"Some patients with your condition have persistent pain even when the inflammation is well controlled — this can happen because the nervous system becomes sensitised to pain signals over time. This tablet works on that central pain pathway. It takes a few weeks to build up. It also helps with mood and sleep, which often suffer with chronic pain."
Important distinction: duloxetine for residual pain in axSpA is appropriate only when inflammation is controlled (BASDAI improving) but neuropathic/central pain persists. Using duloxetine as a substitute for biologic therapy when BASDAI ≥4 = undertreating the underlying disease. Ensure the clinical question "is this residual pain or still active inflammation?" is answered before adding duloxetine.
Validation of the Diagnostic Journey
Years of being told "it's just mechanical back pain" or "nothing on the X-ray" creates iatrogenic self-doubt. The first responsibility of the diagnosing clinician is to validate the patient's experience — to make clear that their symptoms were real, their functional limitation was real, and the condition was missed, not imagined.
"I want to be clear: everything you've experienced — the morning stiffness, the nights you've been woken up, the episodes of iritis — these are symptoms of a real and recognisable condition. It should have been identified sooner. I'm sorry that it wasn't."The Bamboo Spine Fear — Accurate Prognosis
Most patients who have searched online for "ankylosing spondylitis" have encountered images of severe spinal fusion — the stooped, rigid posture of advanced untreated AS. This image is not representative of modern outcomes. With NSAIDs and biologic therapy, most patients diagnosed at Priya's age maintain normal or near-normal spinal mobility. This prognosis must be given explicitly.
"The images you may have seen — people with severe spinal curvature — represent advanced untreated disease. That is not what happens to most people diagnosed at your age with modern treatment. Anti-TNF biologics, which are NICE-approved for your condition, have transformed outcomes."Career as a Physiotherapy Assistant
Priya's occupation — physiotherapy assistant — requires manual handling, prolonged standing, and patient transfers. Untreated axSpA will progressively impair all of these. But the irony is that her professional knowledge of exercise and body mechanics is a therapeutic asset — she will engage with the NASS exercise programme and physiotherapy more effectively than most patients.
"Your understanding of the body is actually an advantage here. You will be able to engage with the exercise programme more intelligently than most patients. With proper treatment, there's no reason why this condition should prevent you from continuing your career."Reproductive Planning and NSAIDs/Biologics
Priya is 28, in a reproductive-age demographic. Family planning must be discussed proactively. NSAIDs must stop before conception or at first positive test. Certolizumab pegol is the preferred biologic if pregnancy is planned. Disease activity often improves in the second and third trimester — this is genuinely encouraging news for patients planning pregnancy.
"If you're thinking about starting a family in the next year or two, I want to plan ahead. The anti-inflammatory tablets need to stop before you conceive or as soon as you have a positive test. But there is a biologic injection that is specifically designed to be safe during pregnancy — your rheumatologist will discuss this."Uveitis Management — Connecting the Dots
Priya has had two previous episodes of uveitis managed by optometrists who did not connect them to the back pain. This disconnection is common and represents a missed diagnostic opportunity. Making the connection explicitly — "your eye problems and your back pain are the same condition" — is the most therapeutically powerful statement of this consultation. It transforms isolated, mysterious, recurrent problems into a unified condition with a coherent treatment plan.
"The two episodes of iritis you've had — those are almost certainly part of the same condition as your back pain. They're both caused by the same immune system activation. Importantly, effective treatment of the spinal condition will likely reduce the frequency of the eye flares as well."Depression, Fatigue, and Chronic Pain
Years of undiagnosed and inadequately managed pain cause depression and fatigue — both from the biological impact of chronic inflammation (cytokines directly suppress mood) and from the psychosocial burden of an invisible, unvalidated condition. PHQ-9 screening at every review. The fatigue in axSpA is frequently underestimated — it is a significant component of the disease burden that NSAIDs address poorly and biologics often improve dramatically.
"How has your mood been through all of this? The fatigue and depression that often come with this condition are as real as the back pain, and they improve with proper treatment. I want to check in about how you're feeling overall."4 Weeks — NSAID Response Review
Has naproxen provided dramatic improvement? (If yes: axSpA diagnosis strongly supported; continue and refer.) BASDAI score at this appointment. MRI SIJ result reviewed. HLA-B27 result. Uveitis history — any new episode? PHQ-9. Physiotherapy referral actioned? Explanation of NICE NG65 referral process provided? Pre-rheumatology appointment checklist completed.
Rheumatology Appointment — Specialist Confirmation
GP to provide: all IBP criteria documented, extra-articular features listed, NSAID trials documented (name, dose, duration, response), BASDAI score, MRI SIJ report, HLA-B27 result, ESR/CRP. Rheumatologist confirms diagnosis using ASAS criteria. Biologic eligibility assessed. SpA-specific physiotherapy referral optimised.
Post-Biologic Initiation — 3 Months
BASDAI and BASFI response to biologic — NICE TA criteria require 50% improvement or BASDAI reduction ≥2 at 12 weeks. Infection screen. PHQ-9 — mood often improves with disease control. CVD risk markers. Ophthalmology — uveitis frequency change? Vaccination check (influenza; no live vaccines). Shared care agreement activated.
Annual Shared Care Review (GP + Rheumatology)
BASDAI, BASFI, chest expansion (BASMI), Schober's. CVD risk: BP, fasting lipids, glucose, smoking status, BMI, Framingham ×1.5 calculation. DEXA at 5 years (osteoporosis surveillance). NSAID safety bloods if continuing. Vaccination review (annual influenza; biologic patient). Uveitis frequency. Reproductive status (NSAID/biologic review if pregnancy planning). PHQ-9. NASS programme engagement. Smoking cessation.
Any Acute Presentation — Uveitis Protocol
Any painful red eye in a patient with known axSpA = same-day ophthalmology referral. Do not manage as conjunctivitis. Do not prescribe topical antibiotics. Contact ophthalmology directly with the axSpA diagnosis stated explicitly. After uveitis resolves: inform rheumatologist — frequency of uveitis flares informs biologic selection (adalimumab/infliximab preferred if recurrent uveitis).
Memory rule
At every axSpA review: BASDAI (disease activity — ≥4 = biologic indication); chest expansion (specific to axSpA — preserve); uveitis frequency (informs biologic choice); CVD risk (annual BP/lipids/glucose — inflammatory arthritis is high CVD risk); NSAID safety bloods (eGFR, BP); biologic monitoring (FBC, LFTs, infection screen); PHQ-9; reproductive status (NSAIDs in pregnancy: contraindicated 3rd trimester; certolizumab if biologic needed).
⚠ Three scenario-specific safety-net phrases
Why safety-netting matters beyond clinical care
- Not making the uveitis–back pain connection explicit
- Managing as mechanical back pain again — not recognising IBP criteria met
- Prescribing PRN rather than continuous NSAID
- Not arranging MRI SIJ (ordering plain X-ray instead)
- Not referring to rheumatology per NICE NG65 (≥4/5 criteria met)
- Not giving the uveitis same-day ophthalmology safety-net
- Not addressing the "bamboo spine" prognosis fear
- NICE NG65 IBP criteria applied (≥4/5 met) → rheumatology referral made
- MRI SIJ arranged (not plain X-ray)
- HLA-B27 + ESR/CRP + BASDAI completed before referral
- Naproxen continuous (not PRN) + PPI co-prescribed
- Uveitis same-day ophthalmology safety-net provided in writing
- Diagnostic delay acknowledged with apology and forward plan
- Uveitis–back pain connection made explicitly ("same condition")
- Bamboo spine fear addressed with accurate prognostic information
- ICE all three explored — diagnostic journey ideas; wheelchair fear; referral expectation
- Reproductive planning raised proactively ("before you need it")
- Closing question asked specifically about pregnancy planning
Who you are
Priya Sharma, 28-year-old physiotherapy assistant at an NHS community rehabilitation team. Degree-educated, physically active, and knowledgeable about musculoskeletal conditions professionally. Married, no children yet. Has been attending GP appointments for 2 years with progressive back pain and has been told on two occasions it is "mechanical back pain." Has been referred for generic physiotherapy twice — neither course helped. Has two previous episodes of acute anterior uveitis (right eye once, left eye once, in the past 3 years), both managed by optometrists. The iritis episodes were not connected to her back pain by any clinician. She is aware there may be a connection but hasn't been told directly.
Hidden agendas (two layers)
Layer 1 — Bamboo spine / wheelchair fear: Priya has searched "inflammatory back pain" online and come across images of ankylosing spondylitis with severe spinal fusion. She is frightened that this is her future. She will not volunteer this unless asked about her concerns specifically. If asked "what's your biggest worry about this?", she will say: "I've seen pictures online of people whose spine completely fuses — I'm worried that's what's going to happen to me." Accurate prognostic information (most people with modern treatment maintain normal function) is the most reassuring thing the candidate can say.
Layer 2 — Reproductive planning: Priya and her husband are "thinking about starting a family in the next couple of years." She is worried about what this means for her medication — she knows ibuprofen is not safe in pregnancy. She will not bring this up unless there is a natural opportunity, or unless the candidate specifically asks about reproductive plans at the end of the consultation.
Clinical details (if asked)
- Back pain: bilateral, centred on the sacroiliac area (low back, slightly lateral, both sides); morning stiffness 45–60 minutes; better after 30 min of activity; waking around 4am with stiffness needing to walk around
- Aggravating: sitting for >30 min, car journeys, evenings watching TV; "I actually feel worse after rest"
- Improving: exercise, gentle yoga, walking — "I actually feel better the more I move"
- NSAID response: "when I've taken proper doses of ibuprofen — like 400mg — it genuinely helps a lot more than paracetamol ever did"
- Uveitis: both episodes were sudden onset, red painful eye, sensitive to light, resolved with eye drops from the optometrist within 2–3 weeks; she was told "iritis" but no cause was identified
- Family history: father has "some kind of back condition" — she thinks it might be similar; uncle has psoriasis
- No IBD symptoms, no psoriasis, no peripheral joint swelling
- PHQ-9 would score around 6 — "I've been getting down about this if I'm honest"
Reactions to key moments
- When IBP criteria are systematically screened: Engaged and grateful — "yes, exactly — that's exactly my experience. Why hasn't anyone asked me that before?"
- When uveitis is connected to back pain: "Oh — really? They're connected? I had a feeling but no one ever said that to me." Visibly relieved.
- When bamboo spine is mentioned/addressed: If candidate asks "what's your biggest worry?" she reveals the fear. If candidate then says most people maintain normal function with modern treatment, she visibly relaxes.
- When told plain X-ray is insufficient: "Oh — so the X-ray wouldn't show it? That makes sense — I've had two X-rays that were normal and kept being told it was fine."
- When rheumatology referral is made: "Thank you — I've been asking for a proper referral for 2 years."
- Challenge line: "My previous GP told me core exercises and physiotherapy were the right treatment. But they haven't helped at all. Am I wrong that this is something different?"
Resolution: Priya will feel fully satisfied if the candidate: (1) screens all 5 IBP criteria; (2) connects the uveitis to the back pain explicitly; (3) arranges MRI SIJ (not just X-ray); (4) makes the rheumatology referral per NICE NG65; (5) addresses the bamboo spine fear with accurate prognosis; (6) provides the uveitis same-day ophthalmology safety-net; (7) raises the reproductive planning question and mentions certolizumab as the pregnancy-safe biologic option. She will disengage if: managed as mechanical back pain again; uveitis not connected; plain X-ray only; no rheumatology referral; bamboo spine fear not addressed.
- Acute anterior uveitis: painful red eye + photophobia → same-day ophthalmology (NOT GP management, NOT topical antibiotics)
- Fracture in ankylosed spine after trauma → emergency CT/MRI
- New neurological deficit in known axSpA → MRI + neurosurgery
- ≥4/5 IBP criteria met in <45 with chronic back pain: NICE NG65 rheumatology referral; MRI SIJ; HLA-B27; BASDAI; NSAID immediately
- BASDAI ≥4 on NSAID therapy: biologic eligibility — rheumatology urgent review
- Established axSpA well-controlled: annual BASDAI, CVD risk, chest expansion, DEXA at 5 yrs
- Biologic monitoring: shared care FBC/LFTs/CRP; annual influenza; no live vaccines